CLINICAL UTILILITY OF LIQUID BIOPSY AS A TOOL TO ASSESS THE EVOLUTION OF BRIGATINIB TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH EML4-ALK TRASLOCATION: AN EXPLORATORY STUDY CUBIK: CLINICAL UTILITY OF LIQUID BIOPSY IN BRIGATINIB ALK+ PATIENTS
2019-002369-36CANCER DEPULMON NO MICROCITICO ALK+Fundación Jiménez DíazInvestigador: DOMINE GOMEZ MANUEL
